Mirae Asset Global Investments Co., Ltd. Immunocore Holdings PLC Transaction History
Mirae Asset Global Investments Co., Ltd.
- $28 Billion
- Q2 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,535 shares of IMCR stock, worth $51,468. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,535
Previous 1,326
15.76%
Holding current value
$51,468
Previous $39,000
23.08%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding IMCR
# of Institutions
147Shares Held
45.1MCall Options Held
297KPut Options Held
1.17M-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.07MShares$237 Million0.14% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$163 Million2.35% of portfolio
-
Wellington Management Group LLP Boston, MA4.21MShares$141 Million0.03% of portfolio
-
Primecap Management CO Pasadena, CA3.77MShares$126 Million0.1% of portfolio
-
Bellevue Group Ag Kuesnacht, V82.44MShares$81.9 Million1.74% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.47B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...